BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnsen KB, Gudbergsson JM, Duroux M, Moos T, Andresen TL, Simonsen JB. On the use of liposome controls in studies investigating the clinical potential of extracellular vesicle-based drug delivery systems - A commentary. J Control Release 2018;269:10-4. [PMID: 29126999 DOI: 10.1016/j.jconrel.2017.11.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Li D, Liu Y, Qin C, Tong L, Xu L. Multifunctional exosome-driven pancreatic cancer diagnostics and therapeutics. Extracellular Vesicle 2023;2:100022. [DOI: 10.1016/j.vesic.2023.100022] [Reference Citation Analysis]
2 Lu M, Xing H, Shao W, Wu P, Fan Y, He H, Barth S, Zheng A, Liang X, Huang Y. Antitumor synergism between PAK4 silencing and immunogenic phototherapy of engineered extracellular vesicles. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.03.020] [Reference Citation Analysis]
3 Fuhrmann G. Drug delivery as a sustainable avenue to future therapies. J Control Release 2023;354:746-54. [PMID: 36690037 DOI: 10.1016/j.jconrel.2023.01.045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lu M, Shao W, Xing H, Huang Y. Extracellular vesicle‐based nucleic acid delivery. Interdisciplinary Medicine 2023. [DOI: 10.1002/inmd.20220007] [Reference Citation Analysis]
5 Al-Jipouri A, Almurisi SH, Al-Japairai K, Bakar LM, Doolaanea AA. Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery. Polymers (Basel) 2023;15. [PMID: 36679199 DOI: 10.3390/polym15020318] [Reference Citation Analysis]
6 Qiao Q, Liu X, Cui K, Li X, Tian T, Yu Y, Niu B, Kong L, Yang C, Zhang Z. Hybrid Biomimetic Nanovesicles to Drive High Lung Biodistribution and Prevent Cytokine Storm for ARDS Treatment. ACS Nano 2022;16:15124-40. [PMID: 36037505 DOI: 10.1021/acsnano.2c06357] [Reference Citation Analysis]
7 Mills H, Acquah R, Tang N, Cheung L, Klenk S, Glassen R, Pirson M, Albert A, Hoang DT, Van TN. A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-7. [DOI: 10.1155/2022/7702512] [Reference Citation Analysis]
8 Xu L, Xie L, Fang C, Lou W, Jiang T. New progress in tumor treatment based on nanoparticles combined with irreversible electroporation. Nano Select 2022. [DOI: 10.1002/nano.202200064] [Reference Citation Analysis]
9 Garbo S, Maione R, Tripodi M, Battistelli C. Next RNA Therapeutics: The Mine of Non-Coding. IJMS 2022;23:7471. [DOI: 10.3390/ijms23137471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ezra Manicum A, Sargazi S, Razzaq S, Kumar GV, Rahdar A, Er S, Ain QU, Bilal M, Aboudzadeh MA. Nano-immunotherapeutic strategies for targeted RNA delivery: Emphasizing the role of monocyte/macrophages as nanovehicles to treat glioblastoma multiforme. Journal of Drug Delivery Science and Technology 2022;71:103288. [DOI: 10.1016/j.jddst.2022.103288] [Reference Citation Analysis]
11 Wang BZ, Luo LJ, Vunjak-Novakovic G. RNA and Protein Delivery by Cell-Secreted and Bioengineered Extracellular Vesicles. Adv Healthc Mater 2022;11:e2101557. [PMID: 34706168 DOI: 10.1002/adhm.202101557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Garcia-carrasco M, Parra-aguilar IF, Gutiérrez-grijalva EP, Licea-claverie A, Basilio Heredia J. Nano-formulations in drug delivery. Food, Medical, and Environmental Applications of Nanomaterials 2022. [DOI: 10.1016/b978-0-12-822858-6.00017-0] [Reference Citation Analysis]
13 Chen C, Wang J, Sun M, Li J, Wang HD. Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery. Biomed Pharmacother 2021;145:112416. [PMID: 34781147 DOI: 10.1016/j.biopha.2021.112416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Mena-Giraldo P, Orozco J. Polymeric Micro/Nanocarriers and Motors for Cargo Transport and Phototriggered Delivery. Polymers (Basel) 2021;13:3920. [PMID: 34833219 DOI: 10.3390/polym13223920] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Liu H, Deng S, Han L, Ren Y, Gu J, He L, Liu T, Yuan ZX. Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy. Colloids Surf B Biointerfaces 2021;209:112163. [PMID: 34736220 DOI: 10.1016/j.colsurfb.2021.112163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
16 Kim H, Jang H, Cho H, Choi J, Hwang KY, Choi Y, Kim SH, Yang Y. Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy. Cancers (Basel) 2021;13:4435. [PMID: 34503245 DOI: 10.3390/cancers13174435] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
17 Escudé Martinez de Castilla P, Tong L, Huang C, Sofias AM, Pastorin G, Chen X, Storm G, Schiffelers RM, Wang JW. Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies. Adv Drug Deliv Rev 2021;175:113801. [PMID: 34015418 DOI: 10.1016/j.addr.2021.05.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 16.5] [Reference Citation Analysis]
18 Zhang LY, Yang X, Wang SB, Chen H, Pan HY, Hu ZM. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System. Curr Top Med Chem 2020;20:2472-92. [PMID: 32962615 DOI: 10.2174/1568026620666200922113054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
19 Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol 2021;16:748-59. [PMID: 34211166 DOI: 10.1038/s41565-021-00931-2] [Cited by in Crossref: 188] [Cited by in F6Publishing: 211] [Article Influence: 94.0] [Reference Citation Analysis]
20 Roerig J, Schiller L, Kalwa H, Hause G, Vissiennon C, Hacker MC, Wölk C, Schulz-Siegmund M. A focus on critical aspects of uptake and transport of milk-derived extracellular vesicles across the Caco-2 intestinal barrier model. Eur J Pharm Biopharm 2021;166:61-74. [PMID: 34077790 DOI: 10.1016/j.ejpb.2021.05.026] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Du C, Li S, Li Y, Galons H, Guo N, Teng Y, Zhang Y, Li M, Yu P. F7 and topotecan co-loaded thermosensitive liposome as a nano-drug delivery system for tumor hyperthermia. Drug Deliv 2020;27:836-47. [PMID: 32508162 DOI: 10.1080/10717544.2020.1772409] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
22 Hui C, Huang H. A study on chitosan-coated liposomes as a carrier of bovine serum albumin as oral protein drug. Journal of Dispersion Science and Technology. [DOI: 10.1080/01932691.2020.1773849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Meng W, He C, Hao Y, Wang L, Li L, Zhu G. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source. Drug Deliv 2020;27:585-98. [PMID: 32264719 DOI: 10.1080/10717544.2020.1748758] [Cited by in Crossref: 118] [Cited by in F6Publishing: 96] [Article Influence: 59.0] [Reference Citation Analysis]
24 Brossa A, Tapparo M, Fonsato V, Papadimitriou E, Delena M, Camussi G, Bussolati B. Coincubation as miR-Loading Strategy to Improve the Anti-Tumor Effect of Stem Cell-Derived EVs. Pharmaceutics 2021;13:76. [PMID: 33429869 DOI: 10.3390/pharmaceutics13010076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Sánchez-fernández J, Cué-sampedro R. Biopolymers and their composites for drug delivery. Green Biocomposites for Biomedical Engineering 2021. [DOI: 10.1016/b978-0-12-821553-1.00018-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Yu F, Zhang Y, Yang C, Li F, Qiu B, Ding W. Enhanced transdermal efficiency of curcumin-loaded peptide-modified liposomes for highly effective antipsoriatic therapy. J Mater Chem B 2021;9:4846-56. [PMID: 34047333 DOI: 10.1039/d1tb00557j] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
27 Chen P, Wang L, Fan X, Ning X, Yu B, Ou C, Chen M. Targeted delivery of extracellular vesicles in heart injury. Theranostics 2021;11:2263-77. [PMID: 33500724 DOI: 10.7150/thno.51571] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
28 Vakhshiteh F, Rahmani S, Ostad SN, Madjd Z, Dinarvand R, Atyabi F. Exosomes derived from miR-34a-overexpressing mesenchymal stem cells inhibit in vitro tumor growth: A new approach for drug delivery. Life Sci 2021;266:118871. [PMID: 33309716 DOI: 10.1016/j.lfs.2020.118871] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
29 Grossen P, Portmann M, Koller E, Duschmalé M, Minz T, Sewing S, Pandya NJ, van Geijtenbeek SK, Ducret A, Kusznir EA, Huber S, Berrera M, Lauer ME, Ringler P, Nordbo B, Jensen ML, Sladojevich F, Jagasia R, Alex R, Gamboni R, Keller M. Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides. Eur J Pharm Biopharm 2021;158:198-210. [PMID: 33248268 DOI: 10.1016/j.ejpb.2020.11.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
30 Hernandez-Oller L, Seras-Franzoso J, Andrade F, Rafael D, Abasolo I, Gener P, Schwartz S Jr. Extracellular Vesicles as Drug Delivery Systems in Cancer. Pharmaceutics 2020;12:E1146. [PMID: 33256036 DOI: 10.3390/pharmaceutics12121146] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
31 Xu L, Faruqu FN, Lim YM, Lim KY, Liam-Or R, Walters AA, Lavender P, Fear D, Wells CM, Tzu-Wen Wang J, Al-Jamal KT. Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatment. Biomaterials 2021;264:120369. [PMID: 32977209 DOI: 10.1016/j.biomaterials.2020.120369] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
32 Elkhoury K, Koçak P, Kang A, Arab-Tehrany E, Ellis Ward J, Shin SR. Engineering Smart Targeting Nanovesicles and Their Combination with Hydrogels for Controlled Drug Delivery. Pharmaceutics 2020;12:E849. [PMID: 32906833 DOI: 10.3390/pharmaceutics12090849] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
33 Pirisinu M, Pham TC, Zhang DX, Hong TN, Nguyen LT, Le MT. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation. Seminars in Cancer Biology 2020. [DOI: 10.1016/j.semcancer.2020.08.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
34 Masterson CH, McCarthy SD, O'Toole D, Laffey JG. The role of cells and their products in respiratory drug delivery: the past, present, and future. Expert Opin Drug Deliv 2020;17:1689-702. [PMID: 32842784 DOI: 10.1080/17425247.2020.1814732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
35 Liu Y, Wu S, Koo Y, Yang A, Dai Y, Khant H, Osman SR, Chowdhury M, Wei H, Li Y, Court K, Hwang E, Wen Y, Dasari SK, Nguyen M, Tang EC, Chehab EW, de Val N, Braam J, Sood AK. Characterization of and isolation methods for plant leaf nanovesicles and small extracellular vesicles. Nanomedicine 2020;29:102271. [PMID: 32702466 DOI: 10.1016/j.nano.2020.102271] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
36 Zhang C, Li M, Tao R, Peng M, Wang Z, Qi Z, Xue X, Wang C. Physiochemical property and antibacterial activity of formulation containing polyprenol extracted from Ginkgo biloba leaves. Industrial Crops and Products 2020;147:112213. [DOI: 10.1016/j.indcrop.2020.112213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Varga Z, Fehér B, Kitka D, Wacha A, Bóta A, Berényi S, Pipich V, Fraikin JL. Size Measurement of Extracellular Vesicles and Synthetic Liposomes: The Impact of the Hydration Shell and the Protein Corona. Colloids Surf B Biointerfaces 2020;192:111053. [PMID: 32361376 DOI: 10.1016/j.colsurfb.2020.111053] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
38 Xue VW, Wong SCC, Song G, Cho WCS. Promising RNA-based cancer gene therapy using extracellular vesicles for drug delivery. Expert Opin Biol Ther 2020;20:767-77. [PMID: 32125904 DOI: 10.1080/14712598.2020.1738377] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
39 Lu M, Huang Y. Bioinspired exosome-like therapeutics and delivery nanoplatforms. Biomaterials 2020;242:119925. [PMID: 32151860 DOI: 10.1016/j.biomaterials.2020.119925] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 28.7] [Reference Citation Analysis]
40 Walker S, Busatto S, Pham A, Tian M, Suh A, Carson K, Quintero A, Lafrence M, Malik H, Santana MX, Wolfram J. Extracellular vesicle-based drug delivery systems for cancer treatment. Theranostics 2019;9:8001-17. [PMID: 31754377 DOI: 10.7150/thno.37097] [Cited by in Crossref: 136] [Cited by in F6Publishing: 150] [Article Influence: 34.0] [Reference Citation Analysis]
41 Lu M, Zhao X, Xing H, Liu H, Lang L, Yang T, Xun Z, Wang D, Ding P. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery. Acta Biomater 2019;96:517-36. [PMID: 31284098 DOI: 10.1016/j.actbio.2019.07.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
42 Wu T, Liu J, Liu M, Liu S, Zhao S, Tian R, Wei D, Liu Y, Zhao Y, Xiao H, Ding B. A Nanobody‐Conjugated DNA Nanoplatform for Targeted Platinum‐Drug Delivery. Angew Chem Int Ed 2019;58:14224-8. [DOI: 10.1002/anie.201909345] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 24.3] [Reference Citation Analysis]
43 Wu T, Liu J, Liu M, Liu S, Zhao S, Tian R, Wei D, Liu Y, Zhao Y, Xiao H, Ding B. A Nanobody‐Conjugated DNA Nanoplatform for Targeted Platinum‐Drug Delivery. Angew Chem 2019;131:14362-6. [DOI: 10.1002/ange.201909345] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
44 Vázquez-Ríos AJ, Molina-Crespo Á, Bouzo BL, López-López R, Moreno-Bueno G, de la Fuente M. Exosome-mimetic nanoplatforms for targeted cancer drug delivery. J Nanobiotechnology 2019;17:85. [PMID: 31319859 DOI: 10.1186/s12951-019-0517-8] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 20.0] [Reference Citation Analysis]
45 Gudbergsson JM, Jønsson K, Simonsen JB, Johnsen KB. Systematic review of targeted extracellular vesicles for drug delivery – Considerations on methodological and biological heterogeneity. Journal of Controlled Release 2019;306:108-20. [DOI: 10.1016/j.jconrel.2019.06.006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 17.5] [Reference Citation Analysis]
46 Ge Y, Tang J, Fu H, Fu Y, Wu Y. Characteristics, Controlled-release and Antimicrobial Properties of Tea Tree Oil Liposomes-incorporated Chitosan-based Electrospun Nanofiber Mats. Fibers Polym 2019;20:698-708. [DOI: 10.1007/s12221-019-1092-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
47 Marazioti A, Papadia K, Kannavou M, Spella M, Basta A, de Lastic AL, Rodi M, Mouzaki A, Samiotaki M, Panayotou G, Stathopoulos GT, Antimisiaris SG. Cellular Vesicles: New Insights in Engineering Methods, Interaction with Cells and Potential for Brain Targeting. J Pharmacol Exp Ther 2019;370:772-85. [PMID: 31061141 DOI: 10.1124/jpet.119.257097] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
48 Zhang M, Zang X, Wang M, Li Z, Qiao M, Hu H, Chen D. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges. J Mater Chem B 2019;7:2421-33. [PMID: 32255119 DOI: 10.1039/c9tb00170k] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 15.0] [Reference Citation Analysis]
49 Simonsen JB. Pitfalls associated with lipophilic fluorophore staining of extracellular vesicles for uptake studies. J Extracell Vesicles 2019;8:1582237. [PMID: 30815239 DOI: 10.1080/20013078.2019.1582237] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 16.5] [Reference Citation Analysis]
50 Chircov C, Grumezescu AM. Basics in nanoarchitectonics. Nanoarchitectonics in Biomedicine 2019. [DOI: 10.1016/b978-0-12-816200-2.00001-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Antimisiaris SG, Mourtas S, Marazioti A. Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery. Pharmaceutics. 2018;10. [PMID: 30404188 DOI: 10.3390/pharmaceutics10040218] [Cited by in Crossref: 266] [Cited by in F6Publishing: 281] [Article Influence: 53.2] [Reference Citation Analysis]
52 Lu M, Zhao X, Xing H, Xun Z, Zhu S, Lang L, Yang T, Cai C, Wang D, Ding P. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA. Int J Pharm 2018;550:100-13. [PMID: 30138707 DOI: 10.1016/j.ijpharm.2018.08.040] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 12.4] [Reference Citation Analysis]
53 Frank J, Richter M, de Rossi C, Lehr CM, Fuhrmann K, Fuhrmann G. Extracellular vesicles protect glucuronidase model enzymes during freeze-drying. Sci Rep 2018;8:12377. [PMID: 30120298 DOI: 10.1038/s41598-018-30786-y] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
54 Goes A, Fuhrmann G. Biogenic and Biomimetic Carriers as Versatile Transporters To Treat Infections. ACS Infect Dis 2018;4:881-92. [PMID: 29553240 DOI: 10.1021/acsinfecdis.8b00030] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]